Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02345837
Other study ID # menoufia ob/gyn
Secondary ID
Status Recruiting
Phase N/A
First received January 20, 2015
Last updated April 4, 2016
Start date February 2014
Est. completion date September 2016

Study information

Verified date April 2016
Source Al Hayat National Hospital
Contact mohamed maher
Phone +966558198655
Email mohamaher2015@gmail.com
Is FDA regulated No
Health authority Egypt: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

The aim of this study is to detect whether or not performing an endometrial sampling in the cycle preceding ovulation induction with clomiphene citrate can improve pregnancy outcomes in the next cycle.


Description:

Patients will be randomized using a list of computer generated random sample into two groups:

Group 1: Couples who will undergo endometrial sampling in the luteal phase of the cycle preceding ovulation induction by clomiphene citrate.

Group 2: Couples who will undergo ovulation induction with clomiphene citrate. The drug chosen for ovulation induction in both groups will be clomephine citrate.

Timing and technique of endometrial sampling:

Timing: from day 15 to day 24 of the cycle preceding ovulation induction cycle. Technique: this will be done using the pipelle method (Williams et al., 2008).

The procedure is as follows:

1. Vaginal speculum to expose the uterine cervix then sterilization by saline.

2. The piston positioned at the extreme distal end of the sheath then the Pipelle is inserted gently through the cervical canal into the cavity of the uterus.

3. While holding the sheath in position with one hand, the other hand rapidly pulls the piston firmly and without interruption.

4. A negative pressure within the sheath will draw the tissue into the curette opening at the distal end of the sheath and captures the separated tissue within its lumen.


Recruitment information / eligibility

Status Recruiting
Enrollment 160
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 35 Years
Eligibility Inclusion Criteria:

1. Male partner should have a normal semen count and motility according to world health organization criteria (Murray et al., 2012).

2. Primary, secondary or unexplained infertility for at least one year.

3. Failure to conceive with clomiphene citrate in spite of good follicular response for at least 3 cycles.

4. Age varies from 20-35 years with at least one year of infertility.

5. Body mass index between 19-30 kg/m2.

6. Day 2 serum FSH< 12 IU/ml.

7. Normal uterine cavity on hystrosalpingography.

8. At least one patent tube of normal appearance on HSG.

9. No previous attempts of intrauterine insemination (IUI) or in vitro fertilization (IVF).

Exclusion Criteria:

1. Infertility due to tubal factor or male factor.

2. Intrauterine organic pathology (myoma, polyp, adhesions) by hystrosalpingogram or diagnostic hysteroscope.

3. Hypogonadotrophic hypogonadism.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
endometrial sampling
injury to the endometrium
Drug:
clomiphene citrate
ovulation induction by 100mg clomiphene citrate

Locations

Country Name City State
Egypt Menoufia University Shebin Elkom

Sponsors (2)

Lead Sponsor Collaborator
Al Hayat National Hospital Menoufia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical pregnancy rate. one year Yes
Primary Miscarriage rate. one year Yes
Primary Multiple pregnancy rates one year Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02740647 - The Efficiency of Postoperative Antibiotics in Orthognathic Surgery N/A
Completed NCT02832310 - The Effects of Valsalva Maneuver on Head, Neck and Upper Extremity Arterial Systems N/A